Edwards Lifesciences SVP, Corporate Controller Disposes Shares
Edwards Lifesciences Corp
Subscribe to track EW
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Insider Sale Alert: Edwards Lifesciences Corp ($EW) Insider: Andrew M. Dahl (SVP, Corporate Controller) Transaction: Sold 544 shares @ $91.06 Total Value: $49,533.92 Remaining Holdings: 14,868.41 shares (Direct) Significance: Low
Comprehensive Analysis
Executive Summary
On August 31, 2026, Andrew M. Dahl, SVP and Corporate Controller of Edwards Lifesciences Corp ($EW), reported the open market sale of 544 shares of common stock at an average price of $91.055 per share. The transaction totaled approximately $49,533.92.
Transaction Details
- Security: Common Stock
- Transaction Type: Open Market Sale (Code S)
- Shares Sold: 544
- Price Per Share: $91.055
- Gross Proceeds: $49,533.92
- Post-Transaction Holdings: 14,868.41 shares (Direct ownership)
Market & Portfolio Context
This sale represents roughly 3.5% of Mr. Dahl's reported direct equity stake prior to the transaction. Given the modest transaction size and the retention of over 14,800 shares, the transaction has Low trading significance and appears routine in nature.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.